Host: Lee Freedman, MD
Guest: Shelley Salpeter, MD
Can metformin safely improve metabolic variables such as weight, lipids, fasting glucose and onset of outright diabetes? Will the improvement in these surrogate endpoints translate into fewer events? Dr. Shelley Salpeter joins host Dr. Lee Freedman to review the rationale for and data behind using metformin in high risk individuals to prevent the onset of type II diabetes mellitus.
